Divya V. Israni

Divya V. Israni

Auto-generated profile, based on publicly available information

Divya V. Israni

Biological Design Center, Boston University, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2022 in Cell
Verified
Journal Article
Closed access
IZIowis Zhu
Iowis Zhu
RLRaymond Liu
Raymond Liu
JGJulie M. Garcia
Julie M. Garcia
AHAxel Hyrenius-Wittsten
Axel Hyrenius-Wittsten
DPDan I. Piraner
Dan I. Piraner
KRKole T. Roybal
Kole T. Roybal

16 December 2022 in Science
Verified
Journal Article
Closed access
HLHui-Shan Li
Hui-Shan Li
DIDivya V. Israni
Divya V. Israni
KGKeith A. Gagnon
Keith A. Gagnon
KGKok Ann Gan
Kok Ann Gan
MRMichael H. Raymond
Michael H. Raymond
AKAhmad S. Khalil
Ahmad S. Khalil
Synthetic gene circuits that precisely control human cell function could expand the capabilities of gene- and cell-based therapies. However, platforms for developing circuits in primary human cells that drive robust functional changes in vivo and have compositions suitable for clinical use are lacking. Here, we developed synthetic zinc finger transcription regulators (synZiFTRs), which are compact and based largely on human-derived proteins. As a proof of principle, we engineered gene switches and circuits that allow precise, user-defined control over therapeutically relevant genes in primary T cells using orthogonal, US Food and Drug Administration–approved small-molecule inducers. Our circuits can instruct T cells to sequentially activate multiple cellular programs such as proliferation and antitumor activity to drive synergistic therapeutic responses. This platform should accelerate the development and clinical translation of synthetic gene circuits in diverse human cell types and contexts.